ATE441653T1 - Phosphorenthaltende verbindugnen mit antithrombitische wirkung - Google Patents

Phosphorenthaltende verbindugnen mit antithrombitische wirkung

Info

Publication number
ATE441653T1
ATE441653T1 AT02770366T AT02770366T ATE441653T1 AT E441653 T1 ATE441653 T1 AT E441653T1 AT 02770366 T AT02770366 T AT 02770366T AT 02770366 T AT02770366 T AT 02770366T AT E441653 T1 ATE441653 T1 AT E441653T1
Authority
AT
Austria
Prior art keywords
compounds
antithrombitic
effect
containing compounds
phosphorus containing
Prior art date
Application number
AT02770366T
Other languages
English (en)
Inventor
Magnus Polla
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE441653T1 publication Critical patent/ATE441653T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/5765—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02770366T 2001-09-28 2002-09-23 Phosphorenthaltende verbindugnen mit antithrombitische wirkung ATE441653T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103272A SE0103272D0 (sv) 2001-09-28 2001-09-28 Chemical compounds
PCT/SE2002/001737 WO2003027128A1 (en) 2001-09-28 2002-09-23 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE441653T1 true ATE441653T1 (de) 2009-09-15

Family

ID=20285515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02770366T ATE441653T1 (de) 2001-09-28 2002-09-23 Phosphorenthaltende verbindugnen mit antithrombitische wirkung

Country Status (7)

Country Link
US (1) US7375121B2 (de)
EP (1) EP1432718B1 (de)
JP (1) JP2005503442A (de)
AT (1) ATE441653T1 (de)
DE (1) DE60233578D1 (de)
SE (1) SE0103272D0 (de)
WO (1) WO2003027128A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100972717B1 (ko) 2002-03-21 2010-07-27 바이엘 쉐링 파마 악티엔게젤샤프트 혈장 카르복시펩티드분해효소 b 억제제
AU2009310841A1 (en) 2008-10-29 2010-05-06 Taisho Pharmaceutical Co., Ltd. Compounds having TAFIa inhibitory activity
RU2015156612A (ru) 2013-06-10 2017-07-17 Санофи Макроциклические производные мочевины в качестве ингибиторов tafia, их получение и их применение в качестве фармацевтических средств
FR3046793B1 (fr) * 2016-01-14 2018-01-05 Les Laboratoires Servier Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046180A (en) * 1996-06-17 2000-04-04 Guilford Pharmaceuticals Inc. NAALADase inhibitors
SE9901572D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
AR023819A1 (es) 1999-05-03 2002-09-04 Astrazeneca Ab FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION
SE9901573D0 (sv) 1999-05-03 1999-05-03 Astra Ab New compounds
WO2001019836A1 (en) 1999-09-14 2001-03-22 Meiji Seika Kaisha, Ltd. Phosphonic acid derivatives having carboxypeptidase b inhibitory activity
PT1311488E (pt) 2000-08-17 2009-12-30 Pfizer Ltd Imidazóis substituídos utilizados como inibidores de tafia

Also Published As

Publication number Publication date
US7375121B2 (en) 2008-05-20
US20040248852A1 (en) 2004-12-09
JP2005503442A (ja) 2005-02-03
EP1432718A1 (de) 2004-06-30
EP1432718B1 (de) 2009-09-02
WO2003027128A1 (en) 2003-04-03
DE60233578D1 (de) 2009-10-15
SE0103272D0 (sv) 2001-09-28

Similar Documents

Publication Publication Date Title
SE9901573D0 (sv) New compounds
RU95102778A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования потерь костной ткани и снижения уровня холестерина в сыворотке, фармацевтический препарат, содержащий 2-фенил-3-ароилбензотиофен
MXPA05001581A (es) Algunas imidazopiridinas novedosas y su uso.
SE0202429D0 (sv) Novel Compounds
BR0317294A (pt) Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com a glicogênio sintase quinase-3 e de prevenção e/ou tratamento de doenças, e, uso dos intermediários
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
CY1107753T1 (el) 2,5-δισυποκατεστημενο 3-μερκαπτοπεντανοϊκο οξυ
GB0310726D0 (en) Therapeutic agents
DK0920865T3 (da) Farmaceutiske sammensætninger indeholdende norastemizol
SE0002476D0 (sv) New compounds
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
SE9901572D0 (sv) New compounds
WO2002064552A8 (en) 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
DE60233578D1 (de) Phosphorenthaltende Verbindugnen mit antithrombitische Wirkung
SE9900190D0 (sv) New compounds
MA27157A1 (fr) Methode de traitement d'affections osseuses.
ATE447953T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
BRPI0415546A (pt) composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios
SE0301904D0 (sv) Novel imidazopyridine compound II with therapeutic effect
DE60022047D1 (de) Antivirale therapie
UY27855A1 (es) Compuestos quimicos
ATE270886T1 (de) Antivirale therapie
ES2173044A1 (es) Glicina, n-(n-l- -glutamil-3-(nitrosotio)-l-valil) y sus aplicaciones.
PT1370526E (pt) Diamidas que inibem a actividade da triptase e do factor xa

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties